Veritable, L.P. Novartis Ag Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $53,291 - $60,428	576 Added 13.2%	4,939 $498,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $1,360 - $1,577	-17 Reduced 0.39%	4,363 $401,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $65,577 - $80,307	868 Added 24.72%	4,380 $397,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $6,491 - $7,591	-87 Reduced 2.42%	3,512 $267,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $10,387 - $12,093	129 Added 3.72%	3,599 $304,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $12,657 - $14,317	-158 Reduced 4.36%	3,470 $304,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $25,424 - $28,113	-319 Reduced 8.08%	3,628 $317,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $2,453 - $2,854	30 Added 0.77%	3,947 $323,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $12,274 - $13,557	-144 Reduced 3.55%	3,917 $357,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $160,654 - $189,456	-1,924 Reduced 32.15%	4,061 $347,000
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $49,808 - $60,246	-638 Reduced 9.63%	5,985 $565,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $205,924 - $228,137	-2,507 Reduced 27.46%	6,623 $576,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $57,703 - $64,954	713 Added 8.47%	9,130 $797,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $6,077 - $8,514	86 Added 1.03%	8,417 $694,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $6,073 - $6,866	-72 Reduced 0.86%	8,331 $789,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $5,731 - $6,315	67 Added 0.8%	8,403 $730,000
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $19,905 - $24,499	264 Added 3.27%	8,336 $761,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $150 - $172	2 Added 0.02%	8,072 $776,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $11,859 - $13,205	-161 Reduced 1.96%	8,070 $692,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $12,049 - $13,937	180 Added 2.24%	8,231 $709,000
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $143,905 - $162,639	-2,217 Reduced 21.59%	8,051 $608,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $3,519 - $4,207	-50 Reduced 0.48%	10,268 $830,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $161,368 - $173,214	2,231 Added 27.59%	10,318 $866,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $599,570 - $624,882	8,087	8,087 $694,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account